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Summary
The normal functions and pathologic facets of the small
presynaptic protein a-synuclein (a-syn) are of exceptional
interest. In previous studies, we found that a-syn attenuates
synaptic exo/endocytosis [1, 2]; however, underlying mech-
anisms remain unknown. More recent evidence suggests
that a-syn exists as metastable multimers and not solely as
a natively unfoldedmonomer [3–8]. However, conformations
of a-syn at synapses—its physiologic locale—are unclear,
and potential implications of such higher-order conforma-
tions to synaptic function are unknown. Exploring a-syn
conformations and synaptic function in neurons, we found
that a-syn promptly organizes into physiological multimers
at synapses. Furthermore, our experiments indicate that
a-syn multimers cluster synaptic vesicles and restrict their
motility, suggesting a novel role for these higher-order
structures. Supporting this, a-syn mutations that disrupt
multimerization also fail to restrict synaptic vesicle motility
or attenuate exo/endocytosis. We propose a model in which
a-syn multimers cluster synaptic vesicles, restricting their
trafficking and recycling, and consequently attenuate neuro-
transmitter release.Results and Discussion
Contemporary Insights into a-Synuclein Biology
The presynaptic bouton is a central communicating hub,
where a sequence of well-orchestrated events leads to exocy-
tosis of neurotransmitter-loaded vesicles into the presynaptic
cleft. A variety of presynaptic proteins participate, mainly as-
sisting in the organization and trafficking of synaptic vesicles.
One such protein is a-syn, which is of singular interest because
of its involvement in Parkinson’s disease and related move-
ment disorders/dementias. In previous studies we found that
small increments in a-syn levels lead to suppression of exo/
endocytosis [1, 2] and that a-syn restricts the lateral mobility
of synaptic vesicles between en-passant boutons [2], called
‘‘superpool’’ trafficking [9]. Along with other studies [10–15],5Present address: Stanford University School of Medicine, 291 Campus
Drive, Stanford, CA 94305, USA
*Correspondence: s1roy@ucsd.eduavailable data advocate the concept that a-syn physiologically
attenuates neurotransmitter release; however, underlying
mechanisms are unclear. a-syn also binds to VAMP2 and pro-
motes SNARE assembly [16], but the consequence of these
interactions on synaptic physiology is uncertain [13, 16].
Regardless, a clear picture of the physiologic role of a-syn
has not emerged yet.
As function often follows form in biology, understanding
physiologic a-syn conformations is important. Recent studies
offer surprising insights, suggesting that a-syn exists as meta-
stable helical multimers, with predominant tetramers [3].
Though this view has been challenged [4, 5], available data
from purified brain a-syn show higher-order multimers and
mixed helical conformations [5, 6], consistent with the idea
that a-syn exists as metastable conformers exchanging be-
tween a monomeric and multimeric state. Even so, key ques-
tions remain unresolved. What is the conformation of a-syn
at synapses, its normal locale? Do a-syn assemblies influence
its function—and if so, how? Here we couple fluorescence-
complementation assays, which selectively stabilize putative
a-syn assemblies, with various cell-biological paradigms to
evaluate vesicle trafficking and synaptic function.
Multimeric a-Syn Conformations at Presynaptic Boutons
Though recent studies have demonstrated a-syn multimers
[3, 7, 8], most experiments used biochemical or biophysical
methods that do not provide spatial information; thus, a-syn
conformations at the presynapse are not entirely clear.We first
evaluated the organization of a-syn at synapses of cultured
neurons using bimolecular fluorescence complementation
(BiFC), an established method to visualize protein-protein in-
teractions [17]. In this assay, one partner of an interacting
pair is tagged to the N terminus fragment of the Venus fluores-
cent protein (VN), while the other partner is tagged to the com-
plimentary C terminus (VC). If and when the two interacting
partners associate, the Venus fragments are reconstituted
and become fluorescent (see schematic in Figure 1Ai). Recon-
stitution is irreversible; thus, even transient interactions can be
‘‘captured’’ by these methods [18].
To mitigate concerns related to overexpression, we used a
‘‘molecular replacement strategy,’’ where the exogenous pro-
tein is expressed in a knockout background, achieving near-
physiologic expression levels [19]. Specifically, we expressed
VN/VC-tagged human wild-type (WT) a-syns (VN/VC:a-syns)
in cultured hippocampal neurons (days in vitro [DIV] 14) from
a-syn null mice and visualized fluorescence after w14 hr
expression (strategy in Figure 1Aii). Expression of human
a-syn in cultured a-syn null neurons was similar to the expres-
sion of native mouse a-syn in parallel-processed cultures (see
below). Three different VN/VC-tagged a-syn combinations
were used (see Supplemental Experimental Procedures avail-
able online). In all cases, robust fluorescence was seen at bou-
tons (Figure 1B, top and Figures S1A and S1B). Cotransfection
of VN and VC alone did not show any synaptic fluorescence
(Figure 1B, bottom; data not shown). Complementation was
also seen in nonneuronal cells as reported previously [21],
and excess untagged a-syn diminished VN/VC:a-syn comple-
mentation in HEK cells, presumably by competition, suggesting
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Figure 1. Multimeric a-Syn Conformations at Presynaptic Boutons
(A) Schematic of complementation assay (i) and molecular replacement strategy (ii). Cultured hippocampal neurons from a-syn 2/2mice were transiently
transfected with various VN/VC-tagged a-syns (see Results and Discussion) and visualized afterw14 hr.
(B) Top: representative images of reconstituted Venus fluorescence in neurons expressing VN/VC:a-syns (also see Figure S1A). Note these neurons are co-
transfected with synaptophysin:mRFP (SyPhy:mRFP) to label boutons. Bottom: no fluorescence was seen in boutons expressing untagged VN + VC alone.
Right: the vast majority (w85%) of SyPhy:mRFP-positive boutons also expressed VN/VC:a-syn, which is comparable to boutons expressing Venus:a-syn
and SyPhy:mRFP (Nw700 boutons for each group from two separate batches of cultures, p = 0.90).
(C) Overall design to compare expression levels of transfected VN/VC:a-syn to endogenous mouse a-syn. Untransfected cultured neurons from WT mice
and VN/VC:a-syn-transfected cultured neurons from a-syn 2/2 mice were fixed and immunostained with an anti-a-syn antibody (guinea pig a-syn anti-
body). Cell culture and immunostaining of both groupswere processed in parallel. Note that while the antibodywould recognizemouse a-syn inWT neurons,
it would only label transfected a-syn in the VN/VC:a-syn transfected group.
(D) Representative images from the two groups in (C) (left) and quantification of overall average fluorescence intensities (right; Nw10 visual fields containing
w3,000–10,000 boutons; p = 0.06). Note that the number of VN/VC:a-syn transfected boutons is much lower than immunostainedWT boutons (as expected
with transient transfections), but the fluorescence intensities are similar.
(E) Overall design. Cultured a-syn 2/2 neurons were cotransfected with VN/VC:a-syns (or Venus:a-syn) + soluble mCherry, and the kinetics of initial a-syn
entry and synaptic accumulation was evaluated by long-term imaging (see Results and Discussion and [20] for more details).
(F) Representative frames from two time-lapse movies showing presynaptic accumulation of VN/VC:a-syn (top) and Venus:a-syn (bottom) over 5 hr of
imaging.
(G) Quantification of average VFP intensities of boutons over 5 hr. Note that although the kinetics of VN/VC:a-syn accumulation (black dots) is slower than
Venus:a-syn (green dots) as expected, the difference is modest, suggesting that complementation is a relatively early event.
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2321that complementation was specific for a-syn (Figure S1C). Syn-
aptic fluorescence due to VN/VC:a-syn complementation was
widespread and seen in virtually all transfected boutons; over-
all, it was similar to neurons transfected with Venus:a-syn
(Figure 1B, graph on right). It is unlikely that the complementa-
tion in our experiments is an artifact of overexpression, as fluo-
rescence intensities of transfected VN/VC:a-syn boutons in
a-syn 2/2 neurons are similar to endogenous mouse a-syn
fluorescence in WT neurons (Figures 1C and 1D; also see
next paragraph).
Next we visualized the time course of accumulation of newly
synthesized VN/VC:a-syn at boutons. We transfected a-syn
null neurons with VN/VC:a-syn (or Venus:a-syn) and visualized
the entry of newly synthesized (somatically derived) fluores-
cent molecules into boutons (4–5 hr after transfection), adopt-
ing an imaging strategy that we recently developed ([20], see
schematic in Figure 1E). Figure 1F shows representative
images from one such experiment. Note that the kinetics of
VN/VC:a-syn entry into boutons is only slightly slower than
Venus:a-syn, quantified in Figure 1G. These data indicate
that multimerization of a-syn is an early event and likely not a
consequence of abnormal long-term intramolecular associa-
tions. Also note that the experimental paradigm (visualizing
entry of newly synthesized proteins into a-syn 2/2 boutons)
further argues that the complementation is unlikely to be a
result of overexpression.
a-Synuclein Multimers Cluster Synaptic Vesicles
Do a-syn multimers have a physiologic role? While qualita-
tively comparing the synaptic VN/VC:a-syn fluorescence with
the fluorescence of endogenous or Venus:a-syn, we noticed
that the reconstituted VN/VC:a-syn fluorescence seemingly
occupied only a subset of the total bouton area. To verify
this, we used a previously described protocol to label the
entire bouton profile (using fluorescent actin, see [22]) and
visualized VN/VC:a-syn fluorescence in these boutons.
Indeed, reconstituted VN/VC:a-syn occupied only a fraction
of the bouton area, as shown in representative bouton crops
(Figure 2A). This distribution is unusual, distinct from
Venus:a-syn that typically occupies the entire bouton (see Fig-
ure S2A). We also developed custom algorithms to quantify
these data. Briefly, as bouton shapes vary, we measured the
cross-sectional area of each bouton along 20 circumferential
angles and then calculated its mean ‘‘synapse width’’ (see Fig-
ure 2B for general concept; see Figure S2B and Supplemental
Experimental Procedures for details). Compiled data from
these analyses are shown in Figures 2C and 2D. Note that
the VN/VC:a-syn fluorescence only occupies a subset of the
bouton cross-sectional area and is indistinguishable from the
area occupied by the synaptic vesicle cluster (labeled with
synaptophysin:GFP, Figure 2C). Furthermore, in neurons
cotransfected with VN/VC:a-syn and synaptophysin:mRFP
(SyPhy:mRFP), there is a significant overlap of fluorescence
(also reflected in correlations between their ‘‘synapse widths,’’
see Figure 2D).
Previous studies expressing WT a-syn in yeast revealed a
dramatic clustering of vesicles by a-syn [23, 24]. Previously,
we found that a-syn restricts synaptic vesicle motility between
en passant boutons [2], suggesting that a-syn might cluster
vesicles within synaptic boutons and restrict vesicle motility.
Since a-syn multimers associate with synaptic vesicles
(above), we asked whether stabilized VN/VC:a-syn multimers
facilitate clustering of synaptic vesicles and inhibit vesicle
motility even further. To test this, we designed an assay todirectly visualize synaptic vesicle dispersion on the basis of
previous observations that neuronal activity disperses synap-
tic vesicles from boutons into flanking axons [25, 26]. Specif-
ically, we asked if stabilized a-syn multimers (reconstituted
VN/VC:a-syns) would attenuate the activity-dependent dis-
persion of synaptic vesicles (labeled with SyPhy:mRFP, see
Figure 2E). Indeed, while Venus:a-syn alone inhibited this
dispersion (as expected), VN/VC:a-syns attenuated this
dispersion even further (Figure 2F and also see Figure 4C
later). Collectively, these experiments suggest that a-syn mul-
timers associate with synaptic vesicle clusters and restrict
their trafficking.
Biochemical Analysis of a-Synuclein Multimers
To biochemically evaluate a-syn multimers, we transiently
introduced VN/VC:a-syns into HEK293 cells or cultured neu-
rons (by adenoviral infections) and analyzed cell lysates by
native or SDS-PAGE gels (Figure 3A). As shown in the native
gels (Figure 3B), only a few higher-order a-syn bands were
typically seen. Though precise molecular weights cannot be
determined by these methods, these bands run at w146 kD
(a-syn tetramers would be expected to run at w114 kD in
our system: 4 a-syns + 2 VFPs). These experiments were
repeated several times with similar results, and notably, all
three VN/VC combinations showed similar biochemical pro-
files (Figure S3A).
Though our above data (Figure 2) suggest that a-syn multi-
mers associate with synaptic vesicles, they do not directly
show vesicle binding. To address this, we evaluated the as-
sociation of monomeric and multimeric a-syn with purified
synaptic vesicles. Based on previously published protocols
[27, 28], we incubated a-syn-free synaptic vesicles and cytosol
with purified monomeric or multimeric a-syn (chemically
crosslinked, see [7]; Figure 3C and Figure S3B). The main
advantage of this assay is that brain cytosolic factors known
to affect a-syn binding to membranes are available, recapitu-
lating the in vivo situation [27]. As shown in Figure 3D, a-syn
multimers are indeed capable of binding to synaptic vesicles,
though multimers are also present in cytosolic fractions. Note
that these data are in general agreement with Dettmer et al.,
2013.
A Mechanistic Link between a-Syn Multimerization and
Synaptic Function
The above data suggest that a-syn multimers associate
with and cluster synaptic vesicles. As a-syn suppresses exo/
endocytosis [1, 2], one can imagine a scenario where a-syn
multimers cluster synaptic vesicles, thus restricting vesicle re-
cycling and, consequently, neurotransmitter release. If cor-
rect, thismodel predicts that disrupting a-synmultimerswould
also diminish a-syn-induced vesicle clustering and abrogate
a-syn-induced synaptic attenuation. Though molecular deter-
minants of a-syn multimerization are unknown, we reasoned
that the most striking feature of the a-syn molecule—N-termi-
nal repeats—might play a role. The N terminus of a-syn has
seven 11-residue repeats that are predicted to fold into amphi-
pathic alpha helices, highly conserved among species [29–31].
Recent simulation models also implicate these repeats in
a-syn tetramerization [32]. We used a rationally designed syn-
thetic mutant, where six threonines (T)—centrally lying along
the helical face of the N terminus—are mutated to lysines (K;
known as TsixK, see Figure 4A and [33]. These mutations are
expected to disrupt significant portions of the extended hydro-
phobic face of the helix and greatly diminish the helical
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Figure 2. a-Syn Multimers Cluster Synaptic Vesicles
(A) Bouton crops from neurons cotransfected with VN/VC:a-syn and mRFP:Actin (to label the entire bouton profile, see Results and Discussion). Note that
reconstituted VN/VC:a-syns only occupy a fraction of the bouton cross-sectional area.
(B) Experimental design. Neurons were cotransfected with VN/VC:a-syn and markers to label the entire bouton profile (mRFP:Actin) or synaptic vesicles
(SyPhy:mRFP), and the extent of overlapwas determined by custom algorithms (see Results andDiscussion and Supplemental Experimental Proceduresfor
details).
(C) Both reconstituted VN/VC:a-syn and SyPhy:GFP occupied a smaller fraction of the bouton than Venus:a-syn (w200 boutons were analyzed for each
group from two separate batches of cultures, ***p < 0.001).
(D) Bouton widths (full-width half-max, see Supplemental Experimental Procedures) of VN/VC:a-syn and SyPhy:mRFP were correlated (left; r = 0.36, p <
0.0001), unlike VN/VC:a-syn andmRFP:Actin (right), further indicating associations of complemented VN/VC:a-syns with synaptic vesicles (N = 120 boutons
from two separate batches of cultures).
(E) Top: schematic of ‘‘synaptic vesicle dispersion assay.’’ Synaptic vesicles are labeled by SyPhy:mRFP, and neurons are stimulated to disperse synaptic
vesicles (see Results and Discussion). Bottom: a time-series showing dispersion of synaptic vesicles from a bouton (elapsed time is in seconds on the lower
left, and the asterisk marks the start of stimulation).
(F) Quantification of synaptic vesicle dispersion using above assay.While Venus:a-syn diminishes dispersion kinetics (comparedwith vector), the dispersion
is further attenuated by VN/VC:a-syn (note that error bars are too small to be seen). The extent of the dispersion is quantified in the inset (19.5%, 13.6%, and
9% of total synaptic vesicles were dispersed in vector, Venus:a-syn, and VN/VC:a-syn groups, respectively; ***p < 0.001, unpaired t test).
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Figure 3. Biochemical Analyses of a-Syn Multimers
(A) VN/VC:a-syns were introduced into HEK293T cells or neurons (by viruses) and expressed for the times indicated, and cell lysates were analyzed by native
or SDS-PAGE.
(B) Native-PAGE show a-syn higher-order multimers immunoblotted with two a-syn antibodies and an anti-GFP antibody that also recognizes YFP (note
disruption upon boiling). The top arrow marks the position where bands are typically seen, and the bottom arrow marks putative monomeric a-syn in neu-
rons. An SDS-PAGE immunoblotted with anti-GFP marks the VFP fragments. Each experiment was repeated 3–5 times with similar results.
(C) In vitro reconstitution assay. Purified synaptic vesicles and cytosol from a-syn 2/2 mouse brains were mixed with WT-a-syn purified from
bacteria with/without a chemical cross linker (DSG). Vesicle membrane bound and unbound fractions were separated by centrifugation and analyzed by
SDS-PAGE.
(D) Both monomeric and crosslinked a-syn multimers bound to synaptic vesicles (a synaptophysin stain confirms that all synaptic vesicles are in the bound
fraction). Top and bottom arrows mark positions of putative tetramers and monomers. The experiment was repeated twice with similar results.
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2323conformation of a-syn [33]. Notably, this reduction in helicity
occurs despite robust association with vesicles [33], and
indeed both WT and TsixK protein bind synaptic vesicles
with equal affinity in our in vitro assay (Figure S3C).
Accordingly, we tested the predictions of our model by
comparing the ability of WT and TsixK mutants to (1) organize
into multimers, (2) cluster synaptic vesicles, and (3) influence
synaptic vesicle recycling. First, we transfected VN/VC pairsof WT a-syns (VN/VC:WT) or TsixK a-syns (VN/VC:TsixK) in
cultured neurons from a-syn 2/2 mice as described previ-
ously. As shown in Figure 4B, fluorescence complementation
in the VN/VC:TsixK a-syns was markedly attenuated. Diminu-
tion of higher-order conformers was also seen biochemically
(Figure S3D). Next, we tested the ability of the TsixK mutant
to suppress activity-induced synaptic vesicle dispersion. As
shown in Figure 4C, while WT a-syn attenuated synaptic
Before Stim
600 AP Stim
NH4Cl
pHluorin-GFP Pseudocolor
5 um
D
A
F
E
VFP (greyscale)
VN
:α
-s
yn
 (W
T)
 +
 
α
-s
yn
 (W
T)
:V
C
VN
:α
-s
yn
 (T
si
xK
) +
 
α
-s
yn
 (T
si
xK
):V
C
VFP (pseudocolor)
vector (N=213)
α-syn (N=193)
TsixK (N=170)
Stim (600 AP)
ve
cto
r
WT
Ts
ixK
0
5
10
15
20
***
Pe
rc
en
ta
ge
 o
f d
isp
er
sio
n
0
1000
2000
3000
***
In
te
ns
ity
 (A
FU
)
VN/VC:WT
(N=1285 boutons)
VN/VC:TsixK
(N=1502 boutons)
B
C
0.0
0.1
0.2
0.3
0.4
0.5
***
ΔΔ
F 6
00
/ Δ
FN
H
4C
l
Vector TsixKWT
20 40 60 80
0.8
0.9
1.0
Time (s)
F/
F0
T22 T33
T59
T81
T92
N
C
T44
10 Hz 
0 50 100 150
0.0
0.5
1.0
Vector (N=159)
WT-α-syn (N=155)
TsixK-α-syn (N=166)
Time (s)
N
or
m
al
iz
ed
 D
el
ta
 F
NH4Cl
Figure 4. Mechanistic Links between a-Syn Mul-
timerization and Synaptic Function
(A) Schematic of the a-syn helices (shaded) and
position of the six mutations.
(B) Neurons from a-syn 2/2 mice were trans-
fected with VN/VC:WT or VN/VC:TsixK a-syns,
and fluorescence was quantified in boutons.
Scale bar represents 5 mm. There were clear dim-
inutions in the TsixK data sets as shown in the
representative images and quantification below.
(C) ‘‘Synaptic vesicle dispersion’’ assay. Neurons
were cotransfected with SyPhy:mRFP (to label
synaptic vesicles) and untagged WT or TsixK
a-syn (or vector alone). Boutons were stimulated
and decay of RFP fluorescence fromboutonswas
quantified (seeResults andDiscussion). Note that
while WT a-syn attenuates activity-induced syn-
aptic vesicle dispersion, the TsixK mutant has
no effect on vesicle trafficking (N = number of
boutons).
(D) Synaptic recycling evaluated by vGlut-
pHluorin assays. Cultured neurons were cotrans-
fected with vGlut-pHluorin and either untagged
WT a-syn or TsixK a-syn. The fluorescence
change of the pH-sensitive vGlut-pHluorin probe
reflects synaptic vesicle recycling in this assay
(see Results, Discussion, and Supplemental
Experimental Procedures). Representative
panels show the fluorescence intensity change
of vGlut-pHluorin upon 600 AP stimulation and
NH4Cl perfusion. Note that NH4Cl alkalinizes all
vesicles, revealing the total (recycling + resting)
pool in these neurons.
(E) Representative ensemble average of vGlut-
pHluorin traces from empty vector, WT a-syn, or
TsixK a-syn transfected neurons (N = number of
boutons). Note that while WT a-syn attenuates
neurotransmitter release and decreases mean re-
cycling pools compared with vector controls,
TsixK a-syn fails to show this effect and is quan-
tified in (F) (all data normalized to total pools).
(F) Recycling:total pool ratio for vector = 43% 6
2.17%; WT a-syn = 28% 6 2.38%; and TsixK
a-syn = 39%6 2.29% (w160 boutons on 7–9 cov-
erslips were analyzed for each group from three
separate batches of cultures; ***p < 0.001
compared with vector by one-way ANOVA followed by Dunnet’s post hoc test). Total (alkalinized) pools of vector, WT-a-syn, and TsixK-a-syn groups
were 317.1 6 16 arbitrary fluorescence units (AFU), 317.5 6 11 AFU, and 376 6 18 AFU (mean 6 SEM), respectively.
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2324vesicle dispersion as expected, the TsixK mutant failed to do
so. Finally, to find whether TsixK mutations also abrogated
the ability of a-syn to attenuate synaptic vesicle recycling,
we used a phluorin-based assay that directly reports synaptic
vesicle recycling ([34, 35]; see Figure 4D). While WT-a-syn
attenuated recycling as reported previously [11], TsixK-a-syn
only had a mild (nonsignificant) effect (Figures 4E and 4F).
Dynamic a-Synuclein Multimers at Synapses
Collectively, the data support a model where synaptic a-syn is
organized into metastable conformers that bind to and cluster
synaptic vesicles, restricting their trafficking. We posit that by
influencing synaptic vesicle trafficking, multimeric a-syn
conformers restrict recycling, consequently attenuating neu-
rotransmitter release. Using complementation assays that
stabilize putative protein-protein interactions, we found that
near-physiologic levels of a-syn result in robust and wide-
spread complementation at synapses (Figure 1). Given the
transient transfection of proteins into an a-syn null back-
ground, the resultant low expression levels (comparable to
endogenous levels, see Figure 1D), and the paradigms usedto visualize initial entry of newly synthesized a-syn into bou-
tons (Figures 1E–1G), it is unlikely that the complementation
seen in our experiments is a result of overexpression. More-
over, data from three different combinations of VN/VC frag-
ments (tagged to a-syns) are similar, untagged a-syn appears
to compete with fluorescence complementation in HEK cells,
and the TsixK a-syn mutant also fails to complement, collec-
tively arguing that complementation is not due to vagaries of
the Venus fragments, but reflect bona fide a-syn interactions.
Clustering Synaptic Vesicles and Regulating
Recycling/Neurotransmitter Release: A Potential
Function of a-Syn Multimers
Do a-syn multimers have a physiologic role? Stabilized VN/
VC:a-syn multimers were associated with synaptic vesicles
(Figures 2A–2D), and also inhibited the trafficking of synaptic
vesicles (Figures 2E and 2F and also Figure 4C). Our biochem-
ical data also show that a-syn multimers can associate with
synaptic vesicles (Figure 3D). Notably, the data do not rule
out a role for cytosolic a-synmultimers. A recent study showed
that purified a-syn protein clusters synthetic vesicles in an
a-Synuclein Multimers Cluster Synaptic Vesicles
2325in vitro lipid-binding assay [36]. Though in isolation, the rele-
vance of these purely in vitro findings to neurons and synapses
is uncertain; in light of data shown here, the collective evi-
dence advocate the concept that a-syn plays a physiologic
role in clustering synaptic vesicles. Supporting the idea that
helical folding of a-syn is important for multimerization, Varkey
et al. recently showed that incubation of a-syn with lipid nano-
particles—known to induce helicity—increases intramolecular
fluorescence resonance energy transfer of a-syn [37]. How-
ever, another recent paper suggests that a-syn is exclusively
involved in attenuating endocytosis [38]. Nevertheless, many
studies indicate that a-syn influences the exocytic cycle and
SNARE assemblies, and amore complete dissection of exocy-
tosis versus endocytosis is warranted. The exact mechanisms
by which a-syn multimers restrict vesicle mobility are still un-
clear. One possibility is that a-synmultimers between adjacent
vesicles associate with each other (an ‘‘interlocking model’’),
with perhaps a-syn/VAMP2 interactions also playing a role,
which is an open question for future studies.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.cub.2014.08.027.
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